$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider
11:15am, Wednesday, 22'nd Jan 2025
Eli Lilly (NYSE: LLY) doesn't really need much of an introduction.
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
09:55am, Wednesday, 22'nd Jan 2025
Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart and kidney diseases as well certain brain ailments.
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
02:35pm, Tuesday, 21'st Jan 2025
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.
Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound
11:24am, Tuesday, 21'st Jan 2025
Shares of Eli Lilly and Company LLY are trading higher after getting pummeled on Friday. The move lower happened after the company announced preliminary sales that were less than expected.
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer's, Study Shows. What It Means for the Stocks.
08:19am, Tuesday, 21'st Jan 2025
Weight-loss medications have exploded in popularity but the health-benefits go beyond obesity.
Eli Lilly: Market Overreacted
05:38am, Tuesday, 21'st Jan 2025
Eli Lilly's Q4 FY24 guidance adjustment is due to supply chain factors, not demand, creating an attractive buying opportunity with a 'Buy' rating. Despite a modest 0.6% revenue reduction, LLY still pr
Should You Buy the Dip in Eli Lilly Stock Right Now?
05:05am, Sunday, 19'th Jan 2025
2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY -4.21%). At one point, share prices had gained as much as 65% on the year.
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
04:22am, Sunday, 19'th Jan 2025
In the first half of 2024, it seemed Eli Lilly (LLY -4.21%) could do no wrong. Unfortunately, the good times didn't last very long.
3 Unstoppable Stocks to Buy in 2025
06:40am, Saturday, 18'th Jan 2025
You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable.
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
06:05am, Saturday, 18'th Jan 2025
GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisk's Ozempic and Eli Lilly's (LLY -4.21%) Mounjaro skyrocketing over the past year. However, Eli Lilly recentl
Dr. Kavita Patel talks impact of GLP-1 price negotiations
06:45pm, Friday, 17'th Jan 2025
Dr. Kavita Patel joins 'Fast Money' to talk what is next for GLP-1 drug makers.
Ozempic, Wegovy among drugs subject to Medicare price controls
11:55am, Friday, 17'th Jan 2025
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
07:30am, Friday, 17'th Jan 2025
Being a long-term investor brings a unique peace of mind. It requires thinking in decades, not months or years, which allows an investor to focus on owning exceptional businesses.
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
04:05am, Friday, 17'th Jan 2025
Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's largest healthcare company, with a market cap that topped $860 billion at one poi
WATCH: 1st Drug Approved For Sleep Apnea Patients
04:00am, Friday, 17'th Jan 2025
VALLEY STREAM, NY — The FDA announced the approval last month of the first drug for patients suffering from obstructive sleep apnea. "This medicine is just another in our arsenal of tools that we ca
Sign In
Buy LLY